Kathleen Tregoning

Insider Reports History

Location
Boston, MA
Signature
/s/ Maegan Deare, Attorney-in-Fact for Kathleen Tregoning
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kathleen Tregoning:

Company Role Class Num Shares Value Price $ Report Date Ownership
Spero Therapeutics, Inc. Director Common Stock 75,000 $54,750 $0.7300 12 Jun 2025 Direct
Cerevel Therapeutics Holdings, Inc. Chief Corporate Affairs Officer Common Stock 0 $0 $41.18 01 Aug 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Corporate Affairs Officer Restricted Stock Units 0 $0 $41.18 01 Aug 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Corporate Affairs Officer Stock Option (Right to Buy) 0 01 Aug 2024 Direct

Insider Reports Filed by Kathleen Tregoning

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SPRO Spero Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 16 Jun 2025, 20:24
/report/000095017024090822-tregoning-kathleen-2024-08-01 Cerevel Therapeutics Holdings, Inc. 01 Aug 2024 3 $0 4 Chief Corporate Affairs Officer 05 Aug 2024, 16:29
SPRO Spero Therapeutics, Inc. 29 May 2024 1 $0 4 Director 30 May 2024, 16:25
/report/000095017024006696-tregoning-kathleen-2024-01-19 Cerevel Therapeutics Holdings, Inc. 19 Jan 2024 1 $0 4 Title: Chief Corporate Affairs Officer 23 Jan 2024, 17:46
SPRO Spero Therapeutics, Inc. 02 Jan 2024 1 +$39,876 4 Director 04 Jan 2024, 16:40
/report/000095017023073592-tregoning-kathleen-2023-12-26 Cerevel Therapeutics Holdings, Inc. 26 Dec 2023 2 +$31,658 4 Title: Chief Corporate Affairs Officer 28 Dec 2023, 16:15
/report/000095017023072363-tregoning-kathleen-2023-12-19 Cerevel Therapeutics Holdings, Inc. 19 Dec 2023 3 -$260,469 4 Title: Chief Corporate Affairs Officer 21 Dec 2023, 20:10
SPRO Spero Therapeutics, Inc. 05 Oct 2023 1 $0 4 Director 10 Oct 2023, 17:29
/report/000089924323004364-tregoning-kathleen-2023-02-06 Cerevel Therapeutics Holdings, Inc. 06 Feb 2023 2 $0 4 Exhibit 24 - Power of Attorney. Officer title: Chief Corporate Affairs Officer 08 Feb 2023, 19:30
SPRO Spero Therapeutics, Inc. 03 Jan 2023 1 +$39,916 4 Director 05 Jan 2023, 15:16
SPRO Spero Therapeutics, Inc. 15 Sep 2022 1 $0 4 Director 19 Sep 2022, 17:39
/report/000089924322005926-tregoning-kathleen-2022-02-09 Cerevel Therapeutics Holdings, Inc. 09 Feb 2022 1 $0 4 Chief Corporate Affairs Officer 11 Feb 2022, 17:39
SPRO Spero Therapeutics, Inc. 05 Jan 2022 1 +$39,985 4 Director 07 Jan 2022, 16:13
SPRO Spero Therapeutics, Inc. 11 Nov 2021 1 $0 4 Director 12 Nov 2021, 15:14
SPRO Spero Therapeutics, Inc. 11 Oct 2021 0 $0 3 Director 14 Oct 2021, 16:48